Sulindac

Chemical formula: C₂₀H₁₇FO₃S  Molecular mass: 356.411 g/mol  PubChem compound: 1548887

Therapeutic indications

Sulindac is indicated for:

Indication

Population group: only adults (18 years old or older)

at least one of
Osteoarthritis
Seropositive rheumatoid arthritis
Seronegative rheumatoid arthritis
Ankylosing spondylitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

at least one of
Gout
Tenonitis
Rheumatoid bursitis
Bursitis of hand
Olecranon bursitis
Trochanteric bursitis
Bursitis of shoulder
Bicipital tendinitis
Calcific tendinitis of shoulder
Gluteal tendinitis
Psoas tendinitis
Patellar tendinitis
Peroneal tendinitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only adolescents (12 years - 18 years old)

Juvenile rheumatoid arthritis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Sulindac is contraindicated in the following cases:

Contraindication

at least one of
Acetylsalicylic acid
Diflunisal
Dimethyl sulfoxide
Eptifibatide
Pregnancy
Lactation

Peptic ulcer

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2014: SULINDAC Tablets
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈